Thomas Crawford, MD

n/a
Baltimore, Maryland

Presentation(s):

• Decision Making in the Use of FDA Approved Treatments for Spinal Muscular Atrophy

  Friday, October 21, 2022
  2:00 PM – 3:15 PM ET

  I do not have any relevant financial / non-financial relationships with any proprietary interests.

• 4 - Review of Novel FDA Approved Treatments for Spinal Muscular Atrophy

  Friday, October 21, 2022
  2:00 PM – 3:15 PM ET

  I do not have any relevant financial / non-financial relationships with any proprietary interests.